Updated December 1 at 3:01pm
49 results total, viewing 1 - 10
Mnemosyne Pharmaceuticals has changed its name to Luc Therapeutics and moved its headquarters from Providence to Cambridge. more
PROVIDENCE — The elements of a mixed-use project that could cover five acres of the former Interstate 195 land were revealed last week in a public overview by the development team. The project, a joint effort of CV Properties LLC of … more
Tivorsan Pharmaceuticals Inc. has named James E. Connolly CEO. The biotechnology company, which focuses on treating Duchenne Muscular Dystrophy and other neuromuscular disorders, also said that Connolly will serve as a member of its board. more
IlluminOss Medical has been issued two patents related to its internal bone fixing system, the company announced Tuesday. more
The Champlin Foundations awarded the University of Rhode Island three grants totaling $421,795 to purchase high-tech equipment to advance education and student learning. more
Rhode Island Medical Imaging has acquired Radiology Associates, a radiology practice. more
(Updated 3:50 and 4:49 p.m.) ProMetic Life Sciences Inc. has entered into a partnership with biotechnology company ProThera Biologics Inc. to develop and commercialize human plasma-derived inter-alpha inhibitor proteins to treat orphan diseases, which are rare diseases affecting fewer than 200,000 people. more
An independent analysis of promising economic clusters for Providence to nurture has identified five stars: life sciences, food processing and packaging, social enterprise, design coupled with advanced manufacturing, and education technology. more
Life sciences company CytoSolv Inc. has been acquired by Semma Therapeutics of Cambridge, Mass., according to a Slater Technology Fund press release. more
Gov. Gina M. Raimondo and Commerce Secretary Stefan Pryor launched three new incentive programs on Wednesday in an effort to grow the state’s economy. more
1 | 2 | 3 | 4 | 5 Next »